Pacific Biosciences Signs Definitive Agreement to Acquire Omniome
Combination aims to transform the genomics landscape and deliver a differentiated product offering into high growth clinical markets...
Pacific Biosciences Signs Definitive Agreement to Acquire Omniome
Vividion Therapeutics Files for IPO
Tempest and Millendo Announce Stockholder Approval of Merger
Lyell Immunopharma Announces Pricing of Initial Public Offering
MorphoSys to buy Constellation Pharma for $1.7 billion; Constellation's stock soars 61%
eFFECTOR Therapeutics and Locust Walk Acquisition Corp. Announce Merger Agreement
Sana Biotechnology Presents Preclinical Data at AACR Meeting 2021
Nuvation Bio Granted Orphan Drug Designation for NUV-422 for Patients with Malignant Gliomas
Vir Biotechnology and GSK Announce VIR-7831 Reduces Hospitalization and Risk of Death in Early Treat